PIK3CA and non-small cell lung carcinoma: Grazini Grazini U U Markovets Markovets A A Ireland Ireland L L Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations Clin Cancer Res Clin Cancer Res 2024 2024 30 30 4143 4143 4154 4154 10.1158/1078-0432.CCR-23-2540 10.1158/1078-0432.CCR-23-2540 supplied-pmid 38630555?